Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperlipidemia and diabetes mellitus

T O'Brien1, T T Nguyen, B R Zimmerman

  • 1Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic Rochester, MN 55905, USA.

Mayo Clinic Proceedings
|October 27, 1998
PubMed
Summary

Diabetic dyslipidemia, including high triglycerides and low HDL, increases coronary artery disease risk. While type 1 diabetes lipid issues often resolve with glycemic control, type 2 diabetes may require further intervention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular and all-cause mortality following acute coronary syndromes in mental health service users.

General hospital psychiatry·2025
Same author

What explains regional variation in privately provided out-of-area residential placement costs for people with intellectual disability in Ireland?

Journal of intellectual disability research : JIDR·2024
Same author

Clinical aptitude.

British dental journal·2023
Same author

The leptin to adiponectin ratio (LAR) is reduced by sleeve gastrectomy in adults with severe obesity: a prospective cohort study.

Scientific reports·2020
Same author

Automated detection of outbreaks of antimicrobial-resistant bacteria in Japan.

The Journal of hospital infection·2018
Same author

Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.

Cell transplantation·2018

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Diabetes mellitus is associated with an increased risk of coronary artery disease.
  • Lipoprotein abnormalities, specifically hypertriglyceridemia and low high-density lipoprotein, are common in diabetes.
  • These lipid abnormalities contribute to cardiovascular risk in diabetic patients.

Purpose of the Study:

  • To review the characteristics and management of dyslipidemia in diabetic patients.
  • To highlight the differences in lipid profile management between type 1 and type 2 diabetes mellitus.
  • To provide recommendations for screening and treatment targets for dyslipidemia in diabetes.

Main Methods:

  • Review of existing literature on diabetes and dyslipidemia.
  • Analysis of lipid abnormalities in type 1 and type 2 diabetes.
  • Evaluation of treatment strategies, including lifestyle modifications and pharmacotherapy.

Main Results:

  • Hypertriglyceridemia and low HDL are prevalent in diabetes.
  • Lipid abnormalities in type 1 diabetes often improve with glycemic control.
  • In type 2 diabetes, lipid abnormalities may persist despite optimal glycemic control, necessitating further management.
  • Lowering LDL cholesterol is proven effective for secondary prevention of coronary artery disease events in diabetic patients.

Conclusions:

  • Screening for dyslipidemia is crucial in all patients with diabetes mellitus.
  • Treatment goals include LDL cholesterol <130 mg/dL and triglycerides <200 mg/dL.
  • Management involves glycemic control, diet, exercise, weight loss, and pharmacotherapy (statins or fibrates) when needed.

Related Experiment Videos